Tag: VTE

Abre stent data show ‘struggle to maintain patency’ among post-thrombotic syndrome...

The Abre venous stent demonstrated three-year primary patency rates of 97.1%, 76.5% and 70.4% respectively for non-thrombotic iliac vein lesion (NIVL), acute deep vein...

FLASH results demonstrate ‘excellent safety profile’ of the FlowTriever system in...

Results of the FLASH registry demonstrate the “excellent safety profile” of the FlowTriever system (Inari Medical) in 800 real-world patients. This is according to Catalin...

Experts establish international standard set of outcome measures for patients with...

The International Consortium for Health Outcomes Measurement (ICHOM) venous thromboembolism (VTE) working group has developed a standard set of outcome measures for patients with...

Key differences in presentation, outcomes for distal versus proximal DVT uncovered

A new study highlights key differences in clinical features and comorbidities, as well as short-term and also long-term outcomes for patients with distal deep...

Compression duration affects pain during superficial venous intervention, study finds

Postprocedural compression of one to two weeks after superficial venous incompetence (SVI) treatment is associated with reduced pain compared with a shorter duration. This...

CLTI, VTE and post-thrombotic syndrome: Leading experts discuss crucial decision-making in...

This advertorial is sponsored by ACHL For Anahita Dua, MBChB, the stark realities and complexities of peripheral arterial disease (PAD) patients undergoing endovascular treatment for...

Strength in numbers: Global VASCC COVID-19 project helps identify framework to...

When Robert Cuff, MD, and Max Wohlauer, MD, first launched the Vascular Surgery COVID-19 Collaborative (VASCC) back in the spring of 2020, the pandemic...

The year in COVID: VAM to feature 10 talks probing pandemic-related...

After nearly 18 months of life dominated by a worldwide pandemic—one that canceled the 2020 Vascular Annual Meeting (VAM)—VAM 2021 highlights several aspects of...

Surmodics builds thrombectomy portfolio with acquisition of Vetex Medical

Surmodics recently announced that it has acquired privately-held Vetex Medical Limited, expanding the company's thrombectomy portfolio with a second Food and Drug Administration (FDA) 510(k)-cleared...

Adjunctive compression to standard prophylaxis for postoperative VTE shows benefit in...

Among patients with a Caprini score of ≥11 who received standard prophylaxis for venous thromboembolism (VTE), adjunctive intermittent pneumatic compression (IPC) resulted in a significantly...

Venous2021 kicks off Wednesday, March 17

The American Venous Forum (AVF) will hold its 33rd annual meeting, Venous2021, in a virtual format from March 17–20. The conference features scientific sessions covering...

AHA, ISTH release joint statement on future VTE research priorities

The American Heart Association (AHA) and the International Society on Thrombosis and Haemostasis (ISTH) issued a joint scientific statement July 8 outlining research priorities...

AHA issues call to action to prevent VTE in hospitalised patients

Venous thromboembolism (VTE) is the leading cause of preventable hospital death in the U.S. and worldwide. A new policy statement from the American Heart...